LDL‐C rebound after long‐term evolocumab treatment and intravascular imaging evidence in a familial hypercholesterolemia patient with early‐onset myocardial infarction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LDL‐C rebound after long‐term evolocumab treatment and intravascular imaging evidence in a familial hypercholesterolemia patient with early‐onset myocardial infarction

Published:2023-10-05 Issue: Volume: Page:
ISSN:2589-0514
Container-title:Chronic Diseases and Translational Medicine
language:en
Short-container-title:Chronic Diseases and Translational Medicine

Author:

Li Zhifan¹,Zhang Shuang¹,Yin Zheng¹,Zhang Wenjia¹,Sui Yonggang¹,Li Jianjun¹,Dou Kefei¹,Qian Jie¹,Wu Naqiong¹^ORCID

Affiliation:

1. Cardiometabolic Center, National Center for Cardiovascular Diseases, Fuwai Hospital Chinese Academy of Medical Science and Peking Union Medical College Beijing China

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cdt3.97

Reference24 articles.

1. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society severe familial hypercholesterolemia panel;Santos RD;Lancet Diabetes Endocrinol,2016

2. Worldwide prevalence of familial hypercholesterolemia;Beheshti SO;J Am Coll Cardiol,2020

3. Familial hypercholesterolemia treatments: guidelines and new therapies;Raal FJ;Atherosclerosis,2018

4. IVUS‐guided versus OCT‐guided coronary stent implantation;Maehara A;JACC Cardiovasc Imag,2017

5. Optical coherence tomography in coronary atherosclerosis assessment and intervention;Araki M;Nat Rev Cardiol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP